nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—seminiferous tubule of testis—hypothyroidism	0.0632	0.16	CbGeAlD
Fulvestrant—ESRRA—Nuclear Receptors—THRA—hypothyroidism	0.0283	0.0705	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0281	0.0698	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0224	0.0557	CbGpPWpGaD
Fulvestrant—ESRRA—Preimplantation Embryo—DLX2—hypothyroidism	0.0202	0.0503	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptors—THRB—hypothyroidism	0.0183	0.0454	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0181	0.045	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptors—THRA—hypothyroidism	0.018	0.0449	CbGpPWpGaD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0164	0.0407	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0144	0.0359	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0142	0.0355	CbGpPWpGaD
Fulvestrant—NR1H4—adrenal cortex—hypothyroidism	0.0141	0.0355	CbGeAlD
Fulvestrant—ESRRA—Preimplantation Embryo—NKX2-1—hypothyroidism	0.0136	0.034	CbGpPWpGaD
Fulvestrant—NR1H4—cardiovascular system—hypothyroidism	0.0128	0.0324	CbGeAlD
Fulvestrant—EPHX2—adrenal cortex—hypothyroidism	0.0123	0.0311	CbGeAlD
Fulvestrant—EPHX2—heart—hypothyroidism	0.0119	0.03	CbGeAlD
Fulvestrant—ESR2—Nuclear Receptors—THRB—hypothyroidism	0.0116	0.0289	CbGpPWpGaD
Fulvestrant—ESRRA—adrenal cortex—hypothyroidism	0.0108	0.0272	CbGeAlD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0105	0.0262	CbGpPWpGaD
Fulvestrant—ESRRA—heart—hypothyroidism	0.0104	0.0263	CbGeAlD
Fulvestrant—NR1H4—adrenal gland—hypothyroidism	0.0102	0.0256	CbGeAlD
Fulvestrant—EPHX2—pituitary gland—hypothyroidism	0.00994	0.0251	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—hypothyroidism	0.00983	0.0248	CbGeAlD
Fulvestrant—NR1H4—female gonad—hypothyroidism	0.00947	0.0239	CbGeAlD
Fulvestrant—CYP3A4—urine—hypothyroidism	0.00933	0.0235	CbGeAlD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00918	0.0229	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.00909	0.0226	CbGpPWpGaD
Fulvestrant—EPHX2—adrenal gland—hypothyroidism	0.00888	0.0224	CbGeAlD
Fulvestrant—EPHX2—blood—hypothyroidism	0.00888	0.0224	CbGeAlD
Fulvestrant—ESRRA—pituitary gland—hypothyroidism	0.00871	0.022	CbGeAlD
Fulvestrant—EPHX2—thyroid gland—hypothyroidism	0.00857	0.0216	CbGeAlD
Fulvestrant—EPHX2—female gonad—hypothyroidism	0.00828	0.0209	CbGeAlD
Fulvestrant—NR1H4—liver—hypothyroidism	0.00794	0.02	CbGeAlD
Fulvestrant—ESRRA—adrenal gland—hypothyroidism	0.00778	0.0196	CbGeAlD
Fulvestrant—ESRRA—blood—hypothyroidism	0.00778	0.0196	CbGeAlD
Fulvestrant—ESRRA—thyroid gland—hypothyroidism	0.00751	0.0189	CbGeAlD
Fulvestrant—EPHX2—testis—hypothyroidism	0.00734	0.0185	CbGeAlD
Fulvestrant—ESRRA—female gonad—hypothyroidism	0.00725	0.0183	CbGeAlD
Fulvestrant—Estradiol—SHBG—hypothyroidism	0.00724	1	CrCbGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00719	0.0179	CbGpPWpGaD
Fulvestrant—EPHX2—liver—hypothyroidism	0.00694	0.0175	CbGeAlD
Fulvestrant—EPHX2—cerebellum—hypothyroidism	0.00678	0.0171	CbGeAlD
Fulvestrant—ESRRA—testis—hypothyroidism	0.00643	0.0162	CbGeAlD
Fulvestrant—ESR2—heart—hypothyroidism	0.00625	0.0158	CbGeAlD
Fulvestrant—ESRRA—liver—hypothyroidism	0.00608	0.0153	CbGeAlD
Fulvestrant—ESRRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.006	0.0149	CbGpPWpGaD
Fulvestrant—ESRRA—cerebellum—hypothyroidism	0.00594	0.015	CbGeAlD
Fulvestrant—ESR2—cardiovascular system—hypothyroidism	0.0059	0.0149	CbGeAlD
Fulvestrant—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.00586	0.0146	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00583	0.0145	CbGpPWpGaD
Fulvestrant—Body temperature increased—Liothyronine—hypothyroidism	0.00569	0.0292	CcSEcCtD
Fulvestrant—ESR2—gonad—hypothyroidism	0.00536	0.0135	CbGeAlD
Fulvestrant—Sweating—Levothyroxine—hypothyroidism	0.00532	0.0273	CcSEcCtD
Fulvestrant—Sweating—Dextrothyroxine—hypothyroidism	0.00532	0.0273	CcSEcCtD
Fulvestrant—NR1H4—Endogenous sterols—POMC—hypothyroidism	0.00527	0.0131	CbGpPWpGaD
Fulvestrant—ESR2—pituitary gland—hypothyroidism	0.00523	0.0132	CbGeAlD
Fulvestrant—ESR2—adrenal gland—hypothyroidism	0.00467	0.0118	CbGeAlD
Fulvestrant—ESR2—blood—hypothyroidism	0.00467	0.0118	CbGeAlD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00463	0.0115	CbGpPWpGaD
Fulvestrant—ESR2—thyroid gland—hypothyroidism	0.0045	0.0114	CbGeAlD
Fulvestrant—NR1H4—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00439	0.0109	CbGpPWpGaD
Fulvestrant—ESR2—female gonad—hypothyroidism	0.00435	0.011	CbGeAlD
Fulvestrant—ESR1—heart—hypothyroidism	0.00428	0.0108	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—hypothyroidism	0.00404	0.0102	CbGeAlD
Fulvestrant—Angioedema—Levothyroxine—hypothyroidism	0.00396	0.0203	CcSEcCtD
Fulvestrant—Angioedema—Dextrothyroxine—hypothyroidism	0.00396	0.0203	CcSEcCtD
Fulvestrant—Sweating—Liotrix—hypothyroidism	0.00391	0.0201	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—THRA—hypothyroidism	0.00387	0.00963	CbGpPWpGaD
Fulvestrant—ESR2—testis—hypothyroidism	0.00386	0.00974	CbGeAlD
Fulvestrant—ESR2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00382	0.00951	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00375	0.00934	CbGpPWpGaD
Fulvestrant—Arthralgia—Levothyroxine—hypothyroidism	0.00369	0.0189	CcSEcCtD
Fulvestrant—Arthralgia—Dextrothyroxine—hypothyroidism	0.00369	0.0189	CcSEcCtD
Fulvestrant—Anxiety—Dextrothyroxine—hypothyroidism	0.00368	0.0189	CcSEcCtD
Fulvestrant—Anxiety—Levothyroxine—hypothyroidism	0.00368	0.0189	CcSEcCtD
Fulvestrant—ESR1—gonad—hypothyroidism	0.00367	0.00926	CbGeAlD
Fulvestrant—ESR2—liver—hypothyroidism	0.00365	0.00921	CbGeAlD
Fulvestrant—ESR1—pituitary gland—hypothyroidism	0.00358	0.00903	CbGeAlD
Fulvestrant—ESR2—cerebellum—hypothyroidism	0.00357	0.009	CbGeAlD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00354	0.0088	CbGpPWpGaD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00342	0.00851	CbGpPWpGaD
Fulvestrant—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00342	0.0176	CcSEcCtD
Fulvestrant—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00342	0.0176	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00322	0.0165	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00322	0.0165	CcSEcCtD
Fulvestrant—Insomnia—Dextrothyroxine—hypothyroidism	0.0032	0.0164	CcSEcCtD
Fulvestrant—Insomnia—Levothyroxine—hypothyroidism	0.0032	0.0164	CcSEcCtD
Fulvestrant—ESR1—adrenal gland—hypothyroidism	0.0032	0.00807	CbGeAlD
Fulvestrant—ESR1—blood—hypothyroidism	0.0032	0.00807	CbGeAlD
Fulvestrant—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00315	0.0162	CcSEcCtD
Fulvestrant—Dyspnoea—Levothyroxine—hypothyroidism	0.00315	0.0162	CcSEcCtD
Fulvestrant—ESR1—thyroid gland—hypothyroidism	0.00309	0.00779	CbGeAlD
Fulvestrant—Fatigue—Dextrothyroxine—hypothyroidism	0.00305	0.0157	CcSEcCtD
Fulvestrant—Fatigue—Levothyroxine—hypothyroidism	0.00305	0.0157	CcSEcCtD
Fulvestrant—ESR1—female gonad—hypothyroidism	0.00298	0.00752	CbGeAlD
Fulvestrant—Angioedema—Liotrix—hypothyroidism	0.00291	0.015	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00289	0.0148	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00289	0.0148	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—ZNF764—hypothyroidism	0.00289	0.00719	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—THRA—hypothyroidism	0.00283	0.00704	CbGpPWpGaD
Fulvestrant—Urticaria—Dextrothyroxine—hypothyroidism	0.00281	0.0144	CcSEcCtD
Fulvestrant—Urticaria—Levothyroxine—hypothyroidism	0.00281	0.0144	CcSEcCtD
Fulvestrant—Body temperature increased—Dextrothyroxine—hypothyroidism	0.0028	0.0144	CcSEcCtD
Fulvestrant—Abdominal pain—Levothyroxine—hypothyroidism	0.0028	0.0144	CcSEcCtD
Fulvestrant—Body temperature increased—Levothyroxine—hypothyroidism	0.0028	0.0144	CcSEcCtD
Fulvestrant—Abdominal pain—Dextrothyroxine—hypothyroidism	0.0028	0.0144	CcSEcCtD
Fulvestrant—ESR2—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00278	0.00693	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00276	0.00686	CbGpPWpGaD
Fulvestrant—Arthralgia—Liotrix—hypothyroidism	0.00271	0.0139	CcSEcCtD
Fulvestrant—Chest pain—Liotrix—hypothyroidism	0.00271	0.0139	CcSEcCtD
Fulvestrant—Anxiety—Liotrix—hypothyroidism	0.0027	0.0139	CcSEcCtD
Fulvestrant—ESR1—testis—hypothyroidism	0.00264	0.00667	CbGeAlD
Fulvestrant—Infection—Liotrix—hypothyroidism	0.00258	0.0133	CcSEcCtD
Fulvestrant—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.00256	0.00638	CbGpPWpGaD
Fulvestrant—Asthenia—Dextrothyroxine—hypothyroidism	0.00254	0.013	CcSEcCtD
Fulvestrant—Asthenia—Levothyroxine—hypothyroidism	0.00254	0.013	CcSEcCtD
Fulvestrant—Hyperhidrosis—Liotrix—hypothyroidism	0.00252	0.0129	CcSEcCtD
Fulvestrant—Pruritus—Dextrothyroxine—hypothyroidism	0.0025	0.0128	CcSEcCtD
Fulvestrant—Pruritus—Levothyroxine—hypothyroidism	0.0025	0.0128	CcSEcCtD
Fulvestrant—ESR1—liver—hypothyroidism	0.0025	0.00631	CbGeAlD
Fulvestrant—ESRRA—Generic Transcription Pathway—THRB—hypothyroidism	0.00249	0.0062	CbGpPWpGaD
Fulvestrant—Anorexia—Liotrix—hypothyroidism	0.00248	0.0127	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—THRA—hypothyroidism	0.00246	0.00613	CbGpPWpGaD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00245	0.0061	CbGpPWpGaD
Fulvestrant—ESR1—cerebellum—hypothyroidism	0.00244	0.00616	CbGeAlD
Fulvestrant—Diarrhoea—Levothyroxine—hypothyroidism	0.00242	0.0124	CcSEcCtD
Fulvestrant—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00242	0.0124	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00237	0.0122	CcSEcCtD
Fulvestrant—Insomnia—Liotrix—hypothyroidism	0.00235	0.0121	CcSEcCtD
Fulvestrant—Paraesthesia—Liotrix—hypothyroidism	0.00234	0.012	CcSEcCtD
Fulvestrant—Dyspnoea—Liotrix—hypothyroidism	0.00232	0.0119	CcSEcCtD
Fulvestrant—Decreased appetite—Liotrix—hypothyroidism	0.00226	0.0116	CcSEcCtD
Fulvestrant—Vomiting—Levothyroxine—hypothyroidism	0.00225	0.0115	CcSEcCtD
Fulvestrant—Vomiting—Dextrothyroxine—hypothyroidism	0.00225	0.0115	CcSEcCtD
Fulvestrant—Fatigue—Liotrix—hypothyroidism	0.00224	0.0115	CcSEcCtD
Fulvestrant—Rash—Levothyroxine—hypothyroidism	0.00223	0.0114	CcSEcCtD
Fulvestrant—Rash—Dextrothyroxine—hypothyroidism	0.00223	0.0114	CcSEcCtD
Fulvestrant—Dermatitis—Levothyroxine—hypothyroidism	0.00223	0.0114	CcSEcCtD
Fulvestrant—Dermatitis—Dextrothyroxine—hypothyroidism	0.00223	0.0114	CcSEcCtD
Fulvestrant—Constipation—Liotrix—hypothyroidism	0.00222	0.0114	CcSEcCtD
Fulvestrant—Headache—Levothyroxine—hypothyroidism	0.00222	0.0114	CcSEcCtD
Fulvestrant—Headache—Dextrothyroxine—hypothyroidism	0.00222	0.0114	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—IYD—hypothyroidism	0.00213	0.0053	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Liotrix—hypothyroidism	0.00213	0.0109	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—ZNF764—hypothyroidism	0.00211	0.00526	CbGpPWpGaD
Fulvestrant—Nausea—Dextrothyroxine—hypothyroidism	0.0021	0.0108	CcSEcCtD
Fulvestrant—Nausea—Levothyroxine—hypothyroidism	0.0021	0.0108	CcSEcCtD
Fulvestrant—Urticaria—Liotrix—hypothyroidism	0.00207	0.0106	CcSEcCtD
Fulvestrant—Abdominal pain—Liotrix—hypothyroidism	0.00206	0.0106	CcSEcCtD
Fulvestrant—Body temperature increased—Liotrix—hypothyroidism	0.00206	0.0106	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00201	0.00501	CbGpPWpGaD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00199	0.00494	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00193	0.00479	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Liotrix—hypothyroidism	0.00192	0.00984	CcSEcCtD
Fulvestrant—Asthenia—Liotrix—hypothyroidism	0.00187	0.00958	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—THRA—hypothyroidism	0.00186	0.00464	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00184	0.00458	CbGpPWpGaD
Fulvestrant—Pruritus—Liotrix—hypothyroidism	0.00184	0.00945	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—ZNF764—hypothyroidism	0.00184	0.00458	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—THRB—hypothyroidism	0.00182	0.00453	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ATP5O—hypothyroidism	0.00181	0.00451	CbGpPWpGaD
Fulvestrant—CYP3A4—blood—hypothyroidism	0.00178	0.0045	CbGeAlD
Fulvestrant—Diarrhoea—Liotrix—hypothyroidism	0.00178	0.00914	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00175	0.00437	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00172	0.00429	CbGpPWpGaD
Fulvestrant—Dizziness—Liotrix—hypothyroidism	0.00172	0.00883	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—TPO—hypothyroidism	0.0017	0.00424	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—IYD—hypothyroidism	0.0017	0.00424	CbGpPWpGaD
Fulvestrant—Vomiting—Liotrix—hypothyroidism	0.00165	0.00849	CcSEcCtD
Fulvestrant—Rash—Liotrix—hypothyroidism	0.00164	0.00842	CcSEcCtD
Fulvestrant—Dermatitis—Liotrix—hypothyroidism	0.00164	0.00841	CcSEcCtD
Fulvestrant—Headache—Liotrix—hypothyroidism	0.00163	0.00837	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—THRB—hypothyroidism	0.00159	0.00395	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00158	0.00393	CbGpPWpGaD
Fulvestrant—Nausea—Liotrix—hypothyroidism	0.00155	0.00793	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00153	0.0038	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00149	0.00372	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ATP5O—hypothyroidism	0.00145	0.0036	CbGpPWpGaD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.0014	0.00349	CbGpPWpGaD
Fulvestrant—CYP3A4—liver—hypothyroidism	0.00139	0.00352	CbGeAlD
Fulvestrant—ESRRA—Metabolism—TPO—hypothyroidism	0.00136	0.00339	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—THRA—hypothyroidism	0.00136	0.00339	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NKX2-5—hypothyroidism	0.00133	0.0033	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00126	0.00314	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—IYD—hypothyroidism	0.00124	0.0031	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.00124	0.00309	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—THRB—hypothyroidism	0.0012	0.00299	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—THRA—hypothyroidism	0.00119	0.00295	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ATP5O—hypothyroidism	0.00106	0.00263	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—POMC—hypothyroidism	0.00105	0.00263	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TPO—hypothyroidism	0.000995	0.00248	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NKX2-5—hypothyroidism	0.00097	0.00241	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ZNF764—hypothyroidism	0.000927	0.00231	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000922	0.00229	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000884	0.0022	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—THRB—hypothyroidism	0.000877	0.00218	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.000863	0.00215	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NKX2-5—hypothyroidism	0.000844	0.0021	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000813	0.00202	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.0008	0.00199	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—TSHB—hypothyroidism	0.000788	0.00196	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—THRB—hypothyroidism	0.000764	0.0019	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000736	0.00183	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3C2A—hypothyroidism	0.000703	0.00175	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000693	0.00173	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—TSHB—hypothyroidism	0.00063	0.00157	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—THRA—hypothyroidism	0.000598	0.00149	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SLC5A5—hypothyroidism	0.00059	0.00147	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00058	0.00144	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3C2A—hypothyroidism	0.000562	0.0014	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000554	0.00138	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC5A5—hypothyroidism	0.000472	0.00117	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TSHB—hypothyroidism	0.000461	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NKX2-5—hypothyroidism	0.000426	0.00106	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3C2A—hypothyroidism	0.000411	0.00102	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00041	0.00102	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000405	0.00101	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—THRB—hypothyroidism	0.000385	0.000958	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000351	0.000873	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC5A5—hypothyroidism	0.000345	0.000858	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—hypothyroidism	0.000309	0.000769	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000284	0.000708	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—hypothyroidism	0.000247	0.000614	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CLTC—hypothyroidism	0.00022	0.000546	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TRH—hypothyroidism	0.00019	0.000472	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—hypothyroidism	0.00018	0.000449	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—IYD—hypothyroidism	0.000178	0.000443	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSHB—hypothyroidism	0.000169	0.000421	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSHR—hypothyroidism	0.000169	0.000421	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000151	0.000377	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000151	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SH2B3—hypothyroidism	0.000151	0.000375	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TPO—hypothyroidism	0.000142	0.000354	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRL—hypothyroidism	0.000112	0.000278	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VAV3—hypothyroidism	0.000103	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AVP—hypothyroidism	9.97e-05	0.000248	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—hypothyroidism	6.62e-05	0.000165	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TSHB—hypothyroidism	6.59e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—hypothyroidism	6.37e-05	0.000159	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	5.88e-05	0.000146	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A5—hypothyroidism	4.94e-05	0.000123	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—hypothyroidism	2.58e-05	6.43e-05	CbGpPWpGaD
